# Supernus Pharmaceuticals, Inc.: Form 8-K, filed Apr 7, 2026

- Company: [Supernus Pharmaceuticals, Inc.](/companies/supn.md) (CIK 1356576)
- Form: 8-K
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 7, 2026, 17:25 ET
- Period: 2026-04-01
- Accession: 0001104659-26-040497
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1356576/000110465926040497/tm2611273d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1356576/000110465926040497/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1356576/000110465926040497/tm2611273d1_8k.htm

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-040497. Last ingested by Listed: Nov 4, 2026, 18:21 ET. No prices; not investment advice.